Shares in Regeneron (NSDQ:REGN) gained today after the biopharmaceutical company crushed earnings expectations on Wall Street with its 3rd quarter results.
The Tarrytown, New York-based company posted profits of $264.8 million, or $2.27 per share, on sales of $1.22 billion for the 3 months ended September 30, for bottom-line growth of 26% on sales growth of 7.3% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Regeneron boosts profits, misses revenue in Q3 appeared first on MassDevice.